The kidney, a cardiovascular risk marker, and a new target for therapy
- 1 September 2005
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 68 (98) , S25-S29
- https://doi.org/10.1111/j.1523-1755.2005.09805.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Continuum of Renoprotection with Losartan at All Stages of Type 2 Diabetic NephropathyJournal of the American Society of Nephrology, 2004
- An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general populationKidney International, 2004
- Proteinuria and the risk of developing end-stage renal diseaseKidney International, 2003
- Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trialEuropean Heart Journal, 2003
- Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination surveyAmerican Journal of Kidney Diseases, 2003
- Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General PopulationCirculation, 2002
- Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized TrialAnnals of Internal Medicine, 2001
- Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart FailureCirculation, 2000
- Urinary Albumin ExcretionArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- The prognostic significance of proteinuria: The Framingham studyAmerican Heart Journal, 1984